NATH BIOGENES (INDIA)
Back to Income Statement
|
NATH BIOGENES (INDIA) Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2013 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹39 Cr | ₹40 Cr | ₹35 Cr | ₹-67 Cr | ₹12 Cr |
What is the latest Consolidated Net Profit of NATH BIOGENES (INDIA) ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹39 Cr |
| Mar2024 | ₹40 Cr |
| Mar2023 | ₹35 Cr |
| Mar2022 | ₹-67 Cr |
| Mar2013 | ₹12 Cr |
How is Consolidated Net Profit of NATH BIOGENES (INDIA) Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹39 Cr | -2.57 | |
| Mar2024 | ₹40 Cr | 13.11 | |
| Mar2023 | ₹35 Cr | Positive | |
| Mar2022 | ₹-67 Cr | Negative | |
| Mar2013 | ₹12 Cr | - | |
Compare Consolidated Net Profit of peers of NATH BIOGENES (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATH BIOGENES (INDIA) | ₹278.7 Cr | -3.5% | -5.1% | -14.1% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹3,592.5 Cr | -4.2% | -10.4% | -37.7% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,410.5 Cr | 0.2% | 12% | 22.3% | Stock Analytics | |
| AVT NATURAL PRODUCTS | ₹1,314.1 Cr | -3.7% | 6% | 16.4% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹903.5 Cr | -5.4% | -6.4% | NA | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹509.8 Cr | -0.3% | 6.9% | 1% | Stock Analytics | |
NATH BIOGENES (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATH BIOGENES (INDIA) | -3.5% |
-5.1% |
-14.1% |
| SENSEX | -2.8% |
-5.2% |
-8.4% |
You may also like the below Video Courses